De novo acute myeloid leukemia in adults younger than 60 years of age: Socioeconomic aspects and treatment results in a Brazilian university center

Leukemia and Lymphoma

Volumn 47, Issue 8, 2006, Pages 1557-1564

  Fagundes, Evandro M ^a   Rocha, Vanderson ^b   Glória, Ana Beatriz F ^a   Clementino, Nelma Cristina D ^a   Quintão, José S ^a   Guimarães, João Paulo O ^a   Pedroso, Ênio Roberto P ^a   Viana, Marcos B ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Adult AML; Developing countries; Socioeconomic status; Treatment outcomes

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFALOTIN; CEFTAZIDIME; CYTARABINE; DAUNORUBICIN; EYE DROPS; GLUCOCORTICOID; MEBENDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID; TIABENDAZOLE; TIOGUANINE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BRAZIL; CONJUNCTIVITIS; CONTROLLED STUDY; DEATH; DISEASE FREE SURVIVAL; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SATISFACTION; PRIORITY JOURNAL; PROBABILITY; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; SOCIOECONOMICS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; ACUTE DISEASE; BRAZIL; CYTARABINE; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; PATIENT SELECTION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 33748529944     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600627055     Document Type: Article

References (30)

1. Lowenberg, B and Downing, J and Burnett, A. (1999) Acute myeloid leukemia N Engl J Med, 341, pp. 1051-1062.
2. Mayer, R and Davis, R and Schiffer, C and Berg, D and Powell, B and Schulman, P and (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia N Engl J Med, 331, pp. 896-903.
3. Zittoun, R and Mandelli, F and Willemze, R and De Witte, T and Labar, B and Resegotti, L and (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia N Engl J Med, 332, pp. 217-223.
4. Harousseau, J and Cahn, J and Pigno, B and Witz, F and Milpied, N and Delain, M and (1997) Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia Blood, 90, pp. 2978-2986.
5. Cassileth, P and Harrington, D and Appelbaum, F and Lazarus, H and Rowe, J and Paietta, E and (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission N Engl J Med, 339, pp. 1649-1656.
6. Burnett, A and Goldstone, A and Stevens, R and Hann, I and Rees, J and Gray, R and Wheatley, K and for the UK Medical Research Council Adult and Children's Leukaemia Working Parties. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of RMC AML 10 trial Lancet, 351, pp. 700-708.
7. Büchner, T and Hiddemann, W and Wörmann, B and Löffler, H and Gassmann, W and Haferlach, T and (1999) Double induction strategy for acute myeloid leukemia: The effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the German AML Cooperative Group Blood, 93, pp. 4116-4124.
8. Mengis, C and Aebi, S and Tobler, A and Dahler, W and Fey, M. (2003) Assessment of differences in patient populations selected or excluded from participation in clinical phase III acute myelogenous leukemia trials J Clin Oncol, 21, pp. 3933-3939.
9. Pulcheri, W and Spector, N and Nucci, M and Morais, J and Pimenta, G and Oliveira, H. (1995) The treatment of acute myeloid leukemia in Brazil: progress and obstacles Haematologica, 80, pp. 130-135.
10. Fagundes, E and Rocha, V and Azevedo, W and Clementino, N and Quintão, J and Ferraz, M and Viana, M. (1995) Leucemia mielóide aguda do adulto: Análise retrospectiva de 99 casos Rev Bras Hematol Hemoter, 7, pp. 33-39.
11. Pagnano, K and Traina, F and Takahashi, T and Oliveira, G and Rossini, M and Lorand-Metze, I and (2000) Conventional chemotherapy for acute myeloid leukemia: A Brazilian experience São Paulo Med J, 118, pp. 173-178.
12. Bittencourt, R and Fogliato, L and Daudt, L and Bittencourt, H and Friederich, J and Fernandes, F and (2003) Leucemia mielóide aguda: Perfil de duas décadas do Serviço de Hematologia do Hospital das Clínicas de Porto Alegre - RS Rev Bras Hematol Hemoter, 25, pp. 15-22.
13. Lobato-Mendizabal, E and Ruiz-Arguelles, G and Gomez-Almaguer, D and Ganci-Cerrud, G and Lozano De La Vega, A and Labardini-Mendez, J. (1991) Long-term treatment and prognostic factors in adult acute myeloblastic leukemia. Experience of the INNSZ group Puebla-Monterrey-Mexico Rev Invest Clin, 43, pp. 215-222.
14. Kakepoto, G and Burney, I and Zaki, S and Adil, S and Khurshid, M. (2002) Long-term outcomes of acute myeloid leukemia in adults in Pakistan J Pak Med Assoc, 52, pp. 482-486.
15. Viana, M and Fernandes, R and Oliveira, B and Murao, M and Paes, C and Duarte, A. (2001) Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia Haematologica, 86, pp. 113-120.
16. Viana, M and Murao, M and Ramos, G and Oliveira, H and De Carvalho, R and De Bastos, M and (1994) Malnutrition as a prognostic factor in lymphoblastic leukaemia: A multivariate analysis Arch Dis Child, 71, pp. 304-310.
17. Viana, M and Fernandes, R and De Carvalho, R and Murao, M. (1998) Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia Int J Cancer, 11, pp. 56-61.
18. Paes, C and Viana, M and Freire, R and Martins-Filho, O and Taboada, D and Rocha, V. (2003) Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children Leuk Res, 27, pp. 789-794.
19. IBGE (Instituto Brasileiro de Estatística). (cited 27 March 2004). Available from: http://www.ibge.gov.br
20. Human Development Reports. (cited 27 March 2004). Available from URL: http://www.undp.org/hdr2003/
21. Human Development Reports. (cited 27 March 2004). Available from URL: http://www.pnud.org.br/index
22. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group Ann Intern Med, 103, pp. 626-629.
23. Grimwade, D and Walker, H and Harrison, G and Oliver, F and Chatters, S and Harrison, C and (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial Blood, 98, pp. 1312-1320.
24. Fenaux, P and Le Deley, M and Castaigne, S and Archimbaud, E and Chomienne, C and Link, H and (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group Blood, 82, pp. 3241-3249.
25. Hughes, W and Armstrong, D and Bodey, G and Brown, A and Edwards, J and Feld, R and (1990) From the Infectious Diseases Society of America guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever J Infec Dis, 161, pp. 381-396.
26. Cheson, B and Cassileth, P and Head, D and Schiffer, C and Bennett, J and Bloomfield, C and (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia J Clin Oncol, 8, pp. 813-819.
27. Byar, D.(1988) Identification of prognostic factors. In Cancer clinical trials: Methods and practice. (pp. 423-443). Oxford: Oxford University Press.
28. Frassoni, F and Labopin, M and Powles, R and Mary, J and Arcese, W and Bacigalupo, A and (2000) Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation Lancet, 355, pp. 1393-1398.
29. Douer, D and Preston-Martin, S and Chang, E and Nichols, P and Watkins, K and Levine, A. (1996) High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia Blood, 87, pp. 308-313.
30. Rego, M and Pinheiro, G and Metze, K and Lorand-Metze, I. (2003) Acute leukemias in Piauí: Comparison with features observed in other regions of Brazil Braz J Med Biol Res, 36, pp. 331-337.